Now showing items 1-1 of 1

    • Recombinant activated factor VII as an adjunctive therapy for bleeding control in severe trauma patients with coagulopathy: Subgroup analysis from two randomized trials 

      Rizoli S.B.; Boffard K.D.; Riou B.; Warren B.L.; Iau P.; Kluger Y.; Rossaint R.; Tillinger M.; Nicol A.; Tracey R.; Marx J.S.S.; Degiannis E.; Goosen J.; Plani F.; Fingleson L.M.; Payen de La Garanderie J.F.; Marty J.; Krivosic-Horber R.; Freysz M.; de La Coussaye J.E.; Duranteau J.; Francois B.; Smail N.; Petit P.; van Aken H.K.; Hempelmann G.; Rivkind A.I.; Shaked G.; Michaelson M.; Choong P.I.T.; Yan A.Y.W.; Hameed S.M.; Samra G.S.; Dobb G.J. (2006)
      Introduction: We conducted a post-hoc analysis on the effect of recombinant factor VIIa (rFVIIa) on coagulopathic patients from two randomized, placebo-controlled, double-blind trials of rFVIIa as an adjunctive therapy for ...